Test the Waters
Macromoltek (yc W18)

Macromoltek (yc W18)

We design custom antibodies using computational modeling to cure diseases faster

Print
Follow
View on Wefunder
Security Type
Equity
Min Investment
$100
Location
Austin, TX
Offering Date
April 06, 2021
Expected Close Date
July 05, 2021
Target Raise
$1.50M
Deal Notes

Future Equity

Company Description

Raised seed funding from Y Combinator, Data Collective VC, Neotribe Ventures, etc. 300+ antibodies engineered & tested. $350k in revenue to date; $450M in the pipeline. Success story includes novel cancer therapeutic designed in <2 weeks, now in pre-clinical trials. Our software-enabled platform reduces traditional process by up to 6x.

Management Team / Advisory Board Bios

Monica Berrondo
Cofounder & CEO
PhD in Chemical Engineering from Johns Hopkins University. Over 15 years Computational Biology leadership. Lead developer of Rosetta Modeling. Austin Founder of the Year. Reviewer for NSF Small Business grants.

Susana Kaufman
Co-founder & CTO
M.SC. Chemical Engineering. Over 20 years in systems development. Developed PageRank for Fintech industry.

Raminderpal Singh
Head of Business Development
Seasoned business development executive, with 20+ years of extensive experience in both the UK and the US. He is passionate about data and computational technologies.

Deal Notes

Future Equity

Amount Raised : $0
Reveal the Score by Voting
＿
0
ⓘ
Business Idea
ⓘ
Business Traction
ⓘ
Management Team
ⓘ
Valuation

Security Description

Equity is a stock or any other security representing a direct ownership interest.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment